Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
112,956
-
Share change
-
+77,918
-
Total reported value
-
$14,252,894
-
Price per share
-
$125.95
-
Number of holders
-
4
-
Value change
-
+$9,813,773
-
Number of buys
-
3
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2023
As of 31 Dec 2023,
Ascendis Pharma A/S - ADR (ASND) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,956 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, JANUS HENDERSON GROUP PLC, T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
183
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.